|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.12 USD | -0.18% |
|
-1.28% | +22.41% |
| Market Cap | 9.76B 8.48B 7.92B 7.27B 13.71B 930B 13.94B 93.36B 36.57B 464B 36.65B 35.84B 1,530B | P/E 2026 * |
12.3x | P/E 2027 * | 9.47x |
|---|---|---|---|---|---|
| Enterprise Value | 11.08B 9.63B 8.99B 8.25B 15.56B 1,056B 15.83B 106B 41.52B 527B 41.62B 40.7B 1,737B | EV / Sales 2026 * |
6.27x | EV / Sales 2027 * | 4.97x |
| Free-Float |
98.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Halozyme Therapeutics, Inc.
| 1 day | -0.17% | ||
| 1 week | -1.28% | ||
| Current month | -0.19% | ||
| 1 month | +1.98% | ||
| 3 months | +27.58% | ||
| 6 months | +5.71% | ||
| Current year | +22.41% |
| 1 week | 81.21 |  | 83.96 |
| 1 month | 73.89 | | 84.44 |
| Current year | 61.32 | | 84.44 |
| 1 year | 59.38 | | 84.44 |
| 3 years | 32.83 | | 84.44 |
| 5 years | 29.85 | | 84.44 |
| 10 years | 8.18 | | 84.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Torley
CEO | Chief Executive Officer | 63 | 2014-01-05 |
David Ramsay
DFI | Director of Finance/CFO | 61 | 2013-04-30 |
| Director of Finance/CFO | - | 2026-06-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 59 | 2013-03-27 |
Helen Torley
BRD | Director/Board Member | 63 | 2014-01-05 |
| Chairman | 61 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Fiscal year | Chief Executive Officer | 5,769 | 0.0049% | ||
| 7/1/26 | Free | Executive/Senior Manager | 56,055 | 0.0473% | ||
| 7/1/26 | Free | Chief Financial Officer | 168,986 | 0.1425% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.18% | -1.28% | +37.32% | +94.25% | 9.76B | |
| +0.50% | -2.83% | +60.39% | +21.99% | 316B | |
| +1.68% | +0.49% | +33.96% | -10.30% | 71.26B | |
| -2.52% | -7.68% | -4.39% | -6.32% | 8.4B | |
| -0.76% | -4.27% | -16.42% | -17.04% | 4.29B | |
| +0.14% | +2.22% | -34.69% | +5.14% | 3.83B | |
| -2.35% | -7.01% | -14.99% | +13.53% | 3.5B | |
| -3.05% | -6.64% | +20.27% | +38.47% | 2.68B | |
| +0.47% | +6.57% | +0.22% | -2.10% | 2.26B | |
| +0.90% | +3.00% | -21.69% | -14.72% | 1.77B | |
| Average | -0.49% | +0.20% | +6.00% | +12.29% | 42.33B | |
| Weighted average by Cap. | +0.60% | -1.67% | +50.95% | +16.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.77B 1.54B 1.43B 1.32B 2.48B 168B 2.53B 16.91B 6.62B 84.02B 6.64B 6.49B 277B | 2B 1.74B 1.63B 1.49B 2.82B 191B 2.86B 19.18B 7.51B 95.28B 7.53B 7.36B 314B |
| Net income | 812M 706M 659M 605M 1.14B 77.4B 1.16B 7.77B 3.04B 38.6B 3.05B 2.98B 127B | 1.03B 899M 839M 770M 1.45B 98.57B 1.48B 9.89B 3.88B 49.16B 3.88B 3.8B 162B |
| Net Debt | 1.32B 1.15B 1.07B 985M 1.86B 126B 1.89B 12.65B 4.96B 62.86B 4.97B 4.86B 207B | 205M 178M 166M 153M 288M 19.53B 293M 1.96B 768M 9.74B 769M 752M 32.12B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | US$82.27 | -0.01% | 102,066 |
| 26-08-03 | US$82.27 | -0.33% | 1,367,693 |
| 26-07-31 | US$82.54 | -0.91% | 1,565,028 |
| 26-07-30 | US$83.30 | +0.02% | 2,135,849 |
| 26-07-29 | US$83.28 | -0.20% | 1,634,260 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HALO Stock
Select your edition
All financial news and data tailored to specific country editions
